Pharmexcil warns Maiden Pharma of export certificate suspension

Published On 2022-10-08 13:00 GMT   |   Update On 2022-10-08 13:00 GMT

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned Haryana-based Maiden Pharma of suspension of the export certificate. The said certificate validates the company as an exporter authorised by the Indian government.WHO on Wednesday issued an alert over four India-made cough and cold syrups which are made by Maiden Pharmaceuticals in India.For more news, check out...

Login or Register to read the full article

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned Haryana-based Maiden Pharma of suspension of the export certificate. The said certificate validates the company as an exporter authorised by the Indian government.

WHO on Wednesday issued an alert over four India-made cough and cold syrups which are made by Maiden Pharmaceuticals in India.

For more news, check out Medical Dialogues:

https://medicaldialogues.in/ 


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News